Advertisement
Screener

RAPT Therapeutics, Inc. Accumulated Other Comprehensive Income

RAPT Therapeutics, Inc. Accumulated Other Comprehensive Income

RAPT Therapeutics, Inc. had Accumulated Other Comprehensive Income of $100.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-06.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2025-11-06

  • 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $100.00K.
  • 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $16.00K.
  • 2025-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $35.00K.
  • 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $50.00K.
Period endAccumulated Other Comprehensive Income (Loss), Net of Tax
2025-09-30$100.00K
10-Q · filed 2025-11-06
2025-06-30$16.00K
10-Q · filed 2025-08-07
2025-03-31$35.00K
10-Q · filed 2025-05-08
2024-12-31$50.00K
10-Q · filed 2025-11-06
2024-09-30$107.00K
10-Q · filed 2024-11-12
2024-06-30-$47.00K
10-Q · filed 2024-08-08
2024-03-31-$10.00K
10-Q · filed 2024-05-09
2023-12-31$103.00K
10-K · filed 2025-03-06
2023-09-30-$121.00K
10-Q · filed 2023-11-13
2023-06-30-$180.00K
10-Q · filed 2023-08-11
2023-03-31$339.00K
10-Q · filed 2023-05-11
2022-12-31-$26.00K
10-K · filed 2024-03-07
2022-09-30-$453.00K
10-Q · filed 2022-11-10
2022-06-30-$745.00K
10-Q · filed 2022-08-11
2022-03-31-$1.12M
10-Q · filed 2022-05-11
2021-12-31-$206.00K
10-K · filed 2023-03-14
2021-09-30$45.00K
10-Q · filed 2021-11-10
2021-06-30-$137.00K
10-Q · filed 2021-08-11
2021-03-31-$189.00K
10-Q · filed 2021-05-11
2020-12-31-$177.00K
10-K · filed 2022-03-10
2020-09-30$74.00K
10-Q · filed 2020-11-16
2020-06-30$177.00K
10-Q · filed 2020-08-13
2020-03-31$7.00K
10-Q · filed 2020-05-14
2019-12-31$20.00K
10-K · filed 2021-03-11
2019-09-30$13.00K
10-Q · filed 2019-12-11
2018-12-31-$4.00K
10-K · filed 2020-03-30